A detailed history of Al Ti Global, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Al Ti Global, Inc. holds 2,495 shares of LLY stock, worth $1.92 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,495
Previous 3,466 28.02%
Holding current value
$1.92 Million
Previous $3.14 Billion 29.57%
% of portfolio
0.05%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $749,747 - $932,179
-971 Reduced 28.02%
2,495 $2.21 Billion
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $2.71 Million - $3.4 Million
-3,745 Reduced 51.93%
3,466 $3.14 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $705,902 - $944,397
1,192 Added 19.8%
7,211 $5.61 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $3.16 Million - $3.73 Million
6,019 New
6,019 $3.51 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.